Subversion of the immune response by Rabies Virus

Viruses

Volumn 8, Issue 8, 2016, Pages

  Scott, Terence P ^a   Nel, Louis H ^a  

^a UNIVERSITY OF PRETORIA   (South Africa)

Author keywords

Apoptosis; Immune evasion; Influencing factors; Rabies; Rabies proteins; Therapeutics

Indexed keywords

ALPHA INTERFERON; BETA INTERFERON; CASPASE; FAS LIGAND; GAMMA INTERFERON; GAMMA INTERFERON INDUCIBLE PROTEIN 10; GLUCOCORTICOID; GLYCINE DEHYDROGENASE (DECARBOXYLATING); HEAT SHOCK PROTEIN; HLA E ANTIGEN; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERFERON REGULATORY FACTOR 3; INTERFERON REGULATORY FACTOR 7; INTERFERON STIMULATED GENE FACTOR 3; INTERLEUKIN 6; MATRIX PROTEIN; MYXOVIRUS RESISTANCE PROTEIN A; NITRIC OXIDE; NUCLEOCYTOPLASMIC TRANSPORT PROTEIN; NUCLEOPROTEIN; PATTERN RECOGNITION RECEPTOR; PROTEIN BCL X; STAT1 PROTEIN; STAT2 PROTEIN; STAT3 PROTEIN; TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND RECEPTOR; UBIQUITIN PROTEIN LIGASE; VIRAL PROTEIN;

ADAPTIVE IMMUNITY; AGE; APOPTOSIS; BRAIN DYSFUNCTION; DEFENSE MECHANISM; GENE EXPRESSION REGULATION; GENETIC POLYMORPHISM; HEMISPHERIC DOMINANCE; HUMAN; IMMUNE EVASION; IMMUNE RESPONSE; INNATE IMMUNITY; MORBIDITY; MORTALITY; NONHUMAN; PROTEIN PROTEIN INTERACTION; RABIES; RABIES VIRUS; REVIEW; SPINAL GANGLION; VIRUS ENTRY; VIRUS LOAD; VIRUS REPLICATION; ANIMAL; HOST PATHOGEN INTERACTION; IMMUNOLOGY; PATHOGENICITY;

ANIMALS; HOST-PATHOGEN INTERACTIONS; HUMANS; IMMUNE EVASION; RABIES VIRUS; VIRUS REPLICATION;

EID: 84983315898     PISSN: None     EISSN: 19994915     Source Type: Journal    
DOI: 10.3390/v8080231     Document Type: Review

References (193)

1. Adamson, P. The spread of rabies into Europe and the probable origin of this disease in antiquity. J. R. Asiat. Soc. Gt. Br. Irel. 1977, 2, 140–144.
2. Pasteur, M.L. Méthode pour prévenir la rage après morsure. C. R. Seances L’Acad. Sci. 1885, 17, 765–772.
3. Dreesen, D.W. A global review of rabies vaccines for human use. Vaccine 1997, 15, S2–S6.
4. Hemachudha, T.; Laothamatas, J.; Rupprecht, C.E. Human rabies: A disease of complex neuropathogenetic mechanisms and diagnostic challenges. Lancet 2002, 1, 101–109.
5. Turner, G.S.; Ballard, R. Interaction of mouse peritoneal macrophages with fixed rabies virus in vivo and in vitro. J. Gen. Virol. 1976, 30, 223–231.
6. Jackson, A.C.; Park, H. Apoptotic cell death in experimental rabies in suckling mice. Acta Neuropathol. 1998, 95, 159–164.
7. Habel, K. Evaluation of a mouse test for the standardization of the immunizing power of anti-rabies vaccines. Public Health Rep. 1940, 55, 1473–1487.
8. Casals, J. Influence of age factors on susceptibility of mice to rabies virus. J. Exp. Med. 1940, 72, 445–451.
9. Aubert, M.F. Practical significance of rabies antibodies in cats and dogs. Rev. Sci. Tech. 1992, 11, 735–760.
10. Mansfield, K.L.; Burr, P.D.; Snodgrass, D.R.; Sayers, R.; Fooks, A.R. Factors affecting the serological response of dogs and cats to rabies vaccination. Vet. Rec. 2004, 154, 423–426.
11. HogenEsch, H.; Thompson, S.; Dunham, A.; Ceddia, M.; Hayek, M. Effect of age on immune parameters and the immune response of dogs to vaccines: A cross-sectional study. Vet. Immunol. Immunopathol. 2004, 97, 77–85.
12. Mastroeni, I.; Vescia, N.; Pompa, M.G.; Cattaruzza, M.S.; Marini, G.P.; Fara, G.M. Immune response of the elderly to rabies vaccines. Vaccine 1994, 12, 518–520.
13. Jackson, A.C.; Warrell, M.J.; Rupprecht, C.E.; Ertl, H.C.J.; Dietzschold, B.; O’Reilly, M.; Leach, R.P.; Fu, Z.F.; Wunner, W.H.; Bleck, T.P.; et al. Management of rabies in humans. Clin. Infect. Dis. 2003, 36, 60–63.
14. Willoughby, R.E. “Early death” and the contraindication of vaccine during treatment of rabies. Vaccine 2009, 27, 7173–7177.
15. Klein, S.L. The effects of hormones on sex differences in infection: From genes to behavior. Neurosci. Behav. Rev. 2000,24, 627–638.
16. Lodmell, D.L. Genetic control of resistance to street rabies virus in mice. J. Exp. Med. 1983, 157, 451–460.
17. Wilde, H.; Chomchey, P.; Punyaratabandhu, P.; Phanupak, P.; Chutivongse, S. Purified equine rabies immune globulin: A safe and affordable alternative to human rabies immune globulin. Bull. World Health Organ. 1989, 67, 731–736.
18. Suwansrinon, K.; Jaijareonsup, W.; Wilde, H.; Benjavongkulchai, M.; Sriaroon, C.; Sitprija, V. Sex- and age-related differences in rabies immunoglobulin hypersensitivity. Trans. R. Soc. Trop. Med. Hyg. 2007, 101, 206–208.
19. Karp, C.L. Unstressing intemperate models: How cold stress undermines mouse modeling. J. Exp. Infect. 2012, 209, 1069–1074.
20. Bell, J.F.; Moore, G.J. Effects of high ambient temperature on various stages of rabies virus infection in mice. Infect. Immun. 1974, 10, 510–515.
21. Wells, C.A.; Ravasi, T.; Faulkner, G.J.; Carninci, P.; Okazaki, Y.; Hayashizaki, Y.; Sweet, M.; Wainwright, B.J.; Hume, D.A. Genetic control of the innate immune response. BMC Immunol. 2003, 4.
22. Noverr, M.C.; Huffnagle, G.B. Does the microbiota regulate immune responses outside the gut? Trends Microbiol. 2004,12, 562–568.
23. Suja, M.S.; Mahadevan, A.; Madhusudana, S.N.; Shankar, S.K. Role of apoptosis in rabies viral encephalitis: A comparative study in mice, canine, and human brain with a review of literature. Pathol. Res. Int. 2011, 2011, 374286.
24. Consales, C.; Bolzan, V. Rabies review: Immunopathology, clinical aspects and treatment. J. Venom. Anim. Toxins Incl. Trop. Dis. 2007, 13, 35–38.
25. Jackson, A.C. Rabies virus infection: An update. J. Neurovirol. 2003, 9, 253–258.
26. Murphy, F.A. Rabies pathogenesis. Arch. Virol. 1977, 54, 279–297.
27. Johnson, N.; Cunningham, A.F.; Fooks, A.R. The immune response to rabies virus infection and vaccination. Vaccine 2010, 28, 3896–3901.
28. Kelly, R.M.; Strick, P.L. Rabies as a transneuronal tracer of circuits in the central nervous system. J. Neurosci. Methods 2000, 103, 63–71.
29. Smart, N.L.; Charlton, K.M. The distribution of challenge virus standard rabies virus versus skunk street rabies virus in the brains of experimentally infected rabid skunks. Acta Neuropathol. 1992, 84, 501–508.
30. Srithayakumar, V.; Sribalachandran, H.; Rosatte, R.; Nadin-Davis, S.A.; Kyle, C.J. Innate immune responses in raccoons after raccoon rabies virus infection. J. Gen. Virol. 2014, 95(Pt 1), 16–25.
31. Kucera, P.; Dolivo, M.; Coulon, P.; Flamand, A. Pathways of the early propagation of virulent and avirulent rabies strains from the eye to the brain. J. Virol. 1985, 55, 158–162.
32. Lycke, E.; Tsiang, H. Rabies virus infection of cultured rat sensory neurons. J. Virol. 1987, 61, 2733–2741.
33. Tsiang, H.; Ceccaldi, P.E.; Lycke, E. Rabies virus infection and transport in human sensory dorsal root ganglia neurons. J. Gen. Virol. 1991, 72, 1191–1194.
34. Siniscalchi, M.; Sasso, R.; Pepe, A.M.; Vallortigara, G.; Quaranta, A. Dogs turn left to emotional stimuli. Behav. Brain Res. 2010, 208, 516–521.
35. Siniscalchi, M.; Sasso, R.; Pepe, A.M.; Dimatteo, S.; Vallortigara, G.; Quaranta, A. Sniffing with the right nostril: Lateralization of response to odour stimuli by dogs. Anim. Behav. 2011, 82, 399–404.
36. Quaranta, A.; Siniscalchi, M.; Vallortigara, G. Asymmetric tail-wagging responses by dogs to different emotive stimuli. Curr. Biol. 2007, 17, R199–R201.
37. Reimchen, T.E.; Spoljaric, M.A. Right paw foraging bias in wild black bear (Ursus americanus kermodei). Laterality 2011,16, 471–478.
38. Komárková, M.; Bartošová, J. Lateralized suckling in domestic horses (Equus caballus). Anim. Cogn. 2013, 16, 343–349.
39. Walker, S.F. Lateralization of functions in the vertebrate brain: A review. Br. J. Psychol. 1980, 71, 329–367.
40. Ghirlanda, S.; Vallortigara, G. The evolution of brain lateralization: A game-theoretical analysis of population structure. Proc. R. Soc. Lond. Biol. Sci. 2004, 271, 853–857.
41. Kim, D.; Carlson, J.N.; Seegal, R.F.; Lawrence, D.A. Differential immune responses in mice with left- and right-turning preference. J. Neuroimmunol. 1999, 93, 164–171.
42. Neveu, P.J. Lateralization and stress responses in mice: Interindividual differences in the association of brain, neuroendocrine, and immune responses. Behav. Genet. 1996, 26, 373–377.
43. Neveu, P.J. Brain asymmetry in neural-immune interactions. Eur. Neuropsychopharmacol. 1991, S18–1, 367–369.
44. Quaranta, A.; Siniscalchi, M.; Frate, A.; Vallortigara, G. Paw preference in dogs: Relations between lateralised behaviour and immunity. Behav. Brain Res. 2004, 153, 521–525.
45. Siniscalchi, M.; Sasso, R.; Pepe, A.M.; Dimatteo, S.; Vallortigara, G.; Quaranta, A. Catecholamine plasma levels following immune stimulation with rabies vaccine in dogs selected for their paw preferences. Neurosci. Lett. 2010, 476, 142–145.
46. Siniscalchi, M.; Cirone, F.; Guaricci, A.C.; Quaranta, A. Catecholamine plasma levels, IFN-γ serum levels and antibodies production induced by rabies vaccine in dogs selected for their paw preference. Laterality 2014, 19, 522–532.
47. Elenkov, I.J.; Wilder, R.L.; Chrousos, G.P.; Vizi, E.S. The sympathetic nerve—An integrative interface between two supersystems: The brain and the immune system. Pharmacol. Rev. 2000, 52, 595–638.
48. Baloul, L.; Camelo, S.; Lafon, M. Up-regulation of Fas ligand (FasL) in the central nervous system: A mechanism of immune evasion by rabies virus. J. Neurovirol. 2004, 10, 372–382.
49. Carson, M.J.; Doose, J.M.; Melchior, B.; Schmid, C.D.; Ploix, C.C. CNS immune privilege: Hiding in plain sight. Immunol. Rev. 2006, 213, 48–65.
50. Lewis, P.; Fu, Y.; Lentz, T.L. Rabies virus entry at the neuromuscular junction in nerve-muscle cocultures. Muscle Nerve 2000, 23, 720–730.
51. Hemachudha, T.; Ugolini, G.; Wacharapluesadee, S.; Sungkarat, W.; Shuangshoti, S.; Laothamatas, J. Human rabies: Neuropathogenesis, diagnosis, and management. Lancet Neurol. 2013, 12, 498–513.
52. Charlton, K.M.; Nadin-Davis, S.; Casey, G.A.; Wandeler, A.I. The long incubation period in rabies: Delayed progression of infection in muscle at the site of exposure. Acta Neuropathol. 1997, 94, 73–77.
53. Yamaoka, S.; Ito, N.; Ohka, S.; Kaneda, S.; Nakamura, H.; Agari, T.; Masatani, T.; Nakagawa, K.; Okada, K.; Okadera, K.; et al. Involvement of the rabies virus phosphoprotein gene in neuroinvasiveness. J. Virol. 2013, 87, 12327–12338.
54. Charlton, K.M.; Casey, G.A. Experimental rabies in skunks: Persistence of virus in denervated muscle at the inoculation site. Can. J. Comp. Med. 1981, 45, 357–362.
55. Mentis, G.Z.; Gravell, M.; Hamilton, R.; Shneider, N.A.; O’Donovan, M.J.; Schubert, M. Transduction of motor neurons and muscle fibers by intramuscular injection of HIV-1-based vectors pseudotyped with select rabies virus glycoproteins. J. Neurosci. Methods 2006, 157, 208–217.
56. Lafon, M. Modulation of the immune response in the nervous system by rabies virus. Curr. Top. Microbiol. Immunol.2005, 289, 239–258.
57. Lentz, T.L.; Burrage, T.G.; Smith, A.L.; Tignor, G.H. The acetylcholine receptor as a cellular receptor for rabies virus.Yale J. Biol. Med. 1983, 56, 315–322.
58. Lafon, M. Evasive Strategies in Rabies Virus Infection, 1st ed.; Elsevier Inc.: Oxford, UK, 2011; Volume 79.
59. Shankar, V.; Dietzschold, B.; Koprowski, H. Direct entry of rabies virus into the central nervous system without prior local replication. J. Virol. 1991, 65, 2736–2738.
60. Thoulouze, M.; Lafage, M.; Montano-hirose, J.A.; Lafon, M. Rabies virus infects mouse and human lymphocytes and induces apoptosis. J. Virol. 1997, 71, 7372–7380.
61. Senba, K.; Matsumoto, T.; Yamada, K.; Shiota, S.; Iha, H.; Date, Y.; Ohtsubo, M.; Nishizono, A. Passive carriage of rabies virus by dendritic cells. Springerplus 2013, 2, 419.
62. King, A.A.; Sands, J.J.; Porterfield, J.S. Antibody-mediated enhancement of rabies virus infection in a mouse macrophage cell line (P388D1). J. Gen. Virol. 1984, 65(Pt 6), 1091–1093.
63. Ray, N.B.; Ewalt, L.C.; Lodmell, D.L. Rabies virus replication in primary murine bone marrow macrophages and in human and murine macrophage-like cell lines: Implications for viral persistence. J. Virol. 1995, 69, 764–772.
64. Benedict, C.A.; Norris, P.S.; Ware, C.F. To kill or be killed: Viral evasion of apoptosis. Nat. Immunol. 2002, 3, 1013–1018.
65. Koyama, A.H. Induction of apoptotic DNA fragmentation by the infection of vesicular stomatitis virus. Virus Res.1995, 37, 285–290.
66. Gougeon, M.-L. Apoptosis as an HIV strategy to escape immune attack. Nat. Rev. Immunol. 2003, 3, 392–404.
67. Faber, M.; Pulmanausahakul, R.; Suchita, S.H.; Spitsin, S.; Mcgettigan, J.P.; Schnell, M.J.; Dietzschold, B. Overexpression of the rabies virus glycoprotein results in enhancement of apoptosis and antiviral immune response.J. Virol. 2002, 76, 3374–3381.
68. Sarmento, L.; Li, X.; Howerth, E.; Jackson, A.C.; Fu, Z.F. Glycoprotein-mediated induction of apoptosis limits the spread of attenuated rabies viruses in the central nervous system of mice. J. Neurovirol. 2005, 11, 571–581.
69. Morimoto, K.; Hooper, D.C.; Spitsin, S.; Koprowski, H.; Dietzschold, B. Pathogenicity of different rabies virus variants inversely correlates with apoptosis and rabies virus glycoprotein expression in infected primary neuron cultures. J. Virol. 1999, 73, 510–518.
70. Prehaud, C.; Lay, S.; Dietzschold, B.; Lafon, M. Glycoprotein of nonpathogenic rabies viruses is a key determinant of human cell apoptosis. J. Virol. 2003, 77, 10537–10547.
71. Dietzschold, B.; Li, J.; Faber, M.; Schnell, M. Concepts in the pathogenesis of rabies. Future Virol. 2009, 3, 481–490.
72. Wirblich, C.; Schnell, M.J. Rabies virus (RV) glycoprotein expression levels are not critical for pathogenicity of RV. J. Virol. 2011, 85, 697–704.
73. Préhaud, C.; Wolff, N.; Terrien, E.; Lafage, M.; Mégret, F.; Babault, N.; Cordier, F.; Tan, G.S.; Maitrepierre, E.; Ménager, P.; et al. Attenuation of rabies virulence: Takeover by the cytoplasmic domain of its envelope protein. Sci. Signal. 2010, 3, ra5.
74. Fu, Z.F.; Jackson, A.C. Neuronal dysfunction and death in rabies virus infection. J. Neurovirol. 2005, 11, 101–106.
75. Thoulouze, M.; Lafage, M.; Schachner, M.; Hartmann, U.; Cremer, H.; Lafon, M. The neural cell adhesion molecule is a receptor for rabies virus. J. Virol. 1998, 72, 7181–7190.
76. Jackson, A.C. Apoptosis in experimental rabies in Bax-deficient mice. Acta Neuropathol. 1999, 98, 288–294.
77. Jackson, A.C.; Rossiter, J.P. Apoptosis plays an important role in experimental rabies virus infection. J. Virol. 1997, 71, 5603–5607.
78. Rutherford, M.; Jackson, A.C. Neuronal apoptosis in immunodeficient mice infected with the challenge virus standard strain of rabies virus by intracerebral inoculation. J. Neurovirol. 2004, 10, 409–413.
79. Jackson, A.C.; Randle, E.; Lawrance, G.; Rossiter, J.P. Neuronal apoptosis does not play an important role in human rabies encephalitis. J. Neurovirol. 2008, 14, 368–375.
80. Reid, J.E.; Jackson, A.C. Experimental rabies virus infection in Artibeus jamaicensis bats with CVS-24 variants. J. Neurovirol. 2001, 7, 511–517.
81. Theerasurakarn, S.; Ubol, S. Apoptosis induction in brain during the fixed strain of rabies virus infection correlates with onset and severity of illness. J. Neurovirol. 1998, 4, 407–414.
82. Li, X.-Q.; Sarmento, L.; Fu, Z.F. Degeneration of neuronal processes after infection with pathogenic, but not attenuated, rabies viruses. J. Virol. 2005, 79, 10063–10068.
83. Jackson, A.C. Diabolical effects of rabies encephalitis. J. Neurovirol. 2016, 22, 1, 8–13.
84. Scott, C.A.; Rossiter, J.P.; Andrew, R.D.; Jackson, A.C. Structural abnormalities in neurons are sufficient to explain the clinical disease and fatal outcome of experimental rabies in yellow fluorescent protein-expressing transgenic mice. J. Virol. 2008, 82, 513–521.
85. Kammouni, W.; Wood, H.; Saleh, A.; Appolinario, C.M.; Fernyhough, P.; Jackson, A.C. Rabies virus phosphoprotein interacts with mitochondrial complex I and induces mitochondrial dysfunction and oxidative stress. J. Neurovirol.2015, 21, 370–382.
86. Gholami, A.; Kassis, R.; Real, E.; Delmas, O.; Guadagnini, S.; Larrous, F.; Obach, D.; Prevost, M.; Jacob, Y.; Bourhy, H. Mitochondrial dysfunction in lyssavirus-induced apoptosis. J. Virol. 2008, 82, 4774–4784.
87. Fernandes, E.; de Andrade, H.; Lancellotti, C. In situ apoptosis of adaptive immune cells and the cellular escape of rabies virus in CNS from patients with human rabies transmitted by Desmodus rotundus. Virus Res. 2011, 156, 121–126.
88. Baloul, L.; Lafon, M. Apoptosis and rabies virus neuroinvasion. Biochimie 2003, 85, 777–788.
89. Adle-Biassette, H.; Bourhy, H.; Gisselbrecht, M.; Chrétien, F.; Wingertsmann, L.; Baudrimont, M.; Rotivel, Y.; Godeau, B.; Gray, F. Rabies encephalitis in a patient with AIDS: A clinicopathological study. Acta Neuropathol. 1996, 92, 415–420.
90. Kasempimolporn, S.; Tirawatnapong, T.; Saengseesom, W.; Nookhai, S.; Sitprija, V. Immunosuppression in rabies virus infection mediated by lymphocyte apoptosis. Jpn. J. Infect. Dis. 2001, 54, 144–147.
91. Lafon, M. Immune Evasion, a Critical Strategy for Rabies Virus. In Towards the Elimination of Rabies in Eurasia; Karger: Basel, Switzerland, 2008; pp. 413–419.
92. Wang, Z.W.; Sarmento, L.; Wang, Y.; Li, X.; Dhingra, V.; Tseggai, T.; Jiang, B.; Zhen, F.; Fu, Z.F. Attenuated rabies virus activates, while pathogenic rabies virus evades, the host innate immune responses in the central nervous system. J. Virol. 2005, 79, 12554–12565.
93. Westendorp, M.O.; Frank, R.; Ochsenbauer, C.; Stricker, K.; Dhein, J.; Walczak, H.; Debating, K.M.; Krammer, P.H. Sensitization of T cells to CD95-mediated apoptosis by HIV-1 Tat and gp120. Nature 1995, 375, 497–500.
94. Flügel, A.; Schwaiger, F.; Neumann, H.; Medana, I.; Willem, M.; Wekerle, H.; Kreutzberg, G.; Graeber, M. Neuronal FasL induces cell death of encephalitogenic T lymphocytes. Brain Pathol. 2000, 10, 353–364.
95. Lafon, M.; Prehaud, C.; Megret, F.; Lafage, M.; Mouillot, G.; Roa, M.; Moreau, P.; Rouas-Freiss, N.; Carosella, E.D. Modulation of HLA-G expression in human neural cells after neurotropic viral infections. J. Virol. 2005, 79, 15226–15237.
96. Mégret, F.; Prehaud, C.; Lafage, M.; Moreau, P.; Rouas-Freiss, N.; Carosella, E.D.; Lafon, M. Modulation of HLA-G and HLA-E expression in human neuronal cells after rabies virus or herpes virus simplex type 1 infections. Hum. Immunol. 2007, 68, 294–302.
97. Wiendl, H.; Mitsdoerffer, M.; Weller, M. Hide-and-seek in the brain: A role for HLA-G mediating immune privilege for glioma cells. Semin. Cancer Biol. 2003, 13, 343–351.
98. Panpanich, T.; Hemachudha, T.; Piyasirisilp, S.; Manatsathit, S.; Wilde, H.; Phanuphak, P. Cells with natural killer activity in human rabies. Clin. Exp. Immunol. 1992, 89, 414–418.
99. Freeman, G.J.; Long, A.J.; Iwai, Y.; Bourque, K.; Chernova, T.; Nishimura, H.; Fitz, L.J.; Malenkovich, N.; Okazaki, T.; Byrne, M.C.; et al. Engagement of the PD-1 immunoinhibitory receptor by a novel B7 family member leads to negative regulation of lymphocyte activation. J. Exp. Med. 2000, 192, 1027–1034.
100. Lafon, M.; Mégret, F.; Meuth, S.G.; Simon, O.; Romero, M.L.V.; Lafage, M.; Chen, L.; Alexopoulou, L.; Flavell, R.A.; Prehaud, C.; et al. Detrimental contribution of the immuno-inhibitor B7-H1 to Rabies Virus Encephalitis. J. Immunol.2008, 180, 7506–7515.
101. Ubol, S.; Sukwattanapan, C.; Maneerat, Y. Inducible nitric oxide synthase inhibition delays death of rabies virus-infected mice. J. Med. Microbiol. 2001, 50, 238–242.
102. Ubol, S.; Sukwattanapan, C.; Utaisincharoen, P. Rabies virus replication induces Bax-related, caspase dependent apoptosis in mouse neuroblastoma cells. Virus Res. 1998, 56, 207–215.
103. Sarmento, L.; Tseggai, T.; Dhingra, V.; Fu, Z.F. Rabies virus-induced apoptosis involves caspase-dependent and caspase-independent pathways. Virus Res. 2006, 121, 144–151.
104. Ubol, S.; Kasisith, J. Reactivation of Nedd-2, a developmentally down-regulated apoptotic gene, in apoptosis induced by a street strain of rabies virus. J. Med. Microbiol. 2000, 49, 1043–1046.
105. Kassis, R.; Larrous, F.; Estaquier, J.; Bourhy, H. Lyssavirus Matrix Protein Induces Apoptosis by a TRAIL-Dependent Mechanism Involving Caspase-8 Activation. J. Virol. 2004, 78, 6543–6555.
106. Larrous, F.; Gholami, A.; Mouhamad, S.; Estaquier, J.; Bourhy, H. Two overlapping domains of a lyssavirus matrix protein that acts on different cell death pathways. J. Virol. 2010, 84, 9897–9906.
107. Zhao, P.; Zhao, L.; Zhang, T.; Qi, Y.; Wang, T.; Liu, K.; Wang, H.; Feng, H.; Jin, H.; Qin, C.; et al. Innate immune response gene expression profiles in central nervous system of mice infected with rabies virus. Comp. Immunol. Microbiol. Infect. Dis. 2011, 34, 503–512.
108. Calabrese, V.; Mancuso, C.; Calvani, M.; Rizzarelli, E.; Butterfield, D.A.; Stella, A.M.G. Nitric oxide in the central nervous system: Neuroprotection versus neurotoxicity. Nat. Rev. Neurosci. 2007, 8, 766–775.
109. Drechsel, D.A.; Estévez, A.G.; Barbeito, L.; Beckman, J.S. Nitric oxide-mediated oxidative damage and the progressive demise of motor neurons in ALS. Neurotox. Res. 2012, 22, 251–264.
110. Ubol, S.; Hiriote, W.; Anuntagool, N.; Utaisincharoen, P. A radical form of nitric oxide suppresses RNA synthesis of rabies virus. Virus Res. 2001, 81, 125–132.
111. Hooper, D.C.; Ohnishi, S.T.; Kean, R.; Numagami, Y.; Dietzschold, B.; Koprowski, H. Local nitric oxide production in viral and autoimmune diseases of the central nervous system. Proc. Natl. Acad. Sci. USA 1995, 92, 5312–5316.
112. Nakamichi, K.; Inoue, S.; Takasaki, T.; Morimoto, K.; Kurane, I. Rabies Virus Stimulates Nitric Oxide Production and CXC Chemokine Ligand 10 Expression in Macrophages through Activation of Extracellular Signal-Regulated Kinases 1 and 2. J. Virol. 2004, 78, 9376–9388.
113. Liao, P.; Hsu, Y.; Yang, H.; Wang, M.; Chen, L. Involvement of extraneural tissues and upregulation of inducible nitric oxide synthase after experimental infection with rabies virus in BALB/c mice and LEW/SsN rats. Pathol. Int. 2012, 62, 619–627.
114. Jackson, A.C.; Kammouni, W.; Zherebitskaya, E.; Fernyhough, P. Role of oxidative stress in rabies virus infection of adult mouse dorsal root ganglion neurons. J. Virol. 2010, 84, 4697–4705.
115. Kammouni, W.; Hasan, L.; Saleh, A.; Wood, H.; Fernyhough, P.; Jackson, A.C. Role of nuclear factor-B in oxidative stress associated with rabies virus infection of adult rat dorsal root ganglion neurons. J. Virol. 2012, 86, 8139–8146.
116. Shin, T.; Weinstock, D.; Castro, M.D.; Hamir, A.N.; Wampler, T.; Walter, M.; Kim, H.Y.; Acland, H. Immunohistochemical localization of endothelial and inducible nitric oxide synthase within neurons of cattle with rabies. J. Vet. Med. Sci. 2004, 66, 539–541.
117. Van Dam, A.-M.; Bauer, J.; Man-A-Hing, W.K.H.; Marquette, C.; Tilders, F.J.H.; Berkenbosch, F. Appearance of inducible nitric oxide synthase in the rat central nervous system after rabies virus infection and during experimental allergic encephalomyelitis but not after peripheral administration of endotoxin. J. Neurosci. Res. 1995, 40, 251–260.
118. Yan, X.; Prosniak, M.; Curtis, M.T.; Weiss, M.L.; Faber, M.; Dietzschold, B.; Fu, Z.F. Silver-haired bat rabies virus variant does not induce apoptosis in the brain of experimentally infected mice. J. Neurovirol. 2001, 7, 518–527.
119. Guigoni, C.; Coulon, P. Rabies virus is not cytolytic for rat spinal motoneurons in vitro. J. Neurovirol. 2002, 8, 306–317.
120. Koprowski, H.; Zheng, Y.M.; Heber-Katz, E.; Fraser, N.; Rorke, L.; Fu, Z.F.; Hanlon, C.; Dietzschold, B. In vivo expression of inducible nitric oxide synthase in experimentally induced neurologic diseases. Proc. Natl. Acad. Sci. USA 1993, 90, 3024–3027.
121. Alandijany, T.; Kammouni, W.; Roy Chowdhury, S.K.; Fernyhough, P.; Jackson, A.C. Mitochondrial dysfunction in rabies virus infection of neurons. J. Neurovirol. 2013, 19, 537–549.
122. Teepker, M.; Anthes, N.; Fischer, S.; Krieg, J.C.; Vedder, H. Effects of oxidative challenge and calcium on ATP-levels in neuronal cells. Neurotoxicology 2007, 28, 19–26.
123. Lambert, A.; Brand, M. Reactive Oxygen Species Production by Mitochondria. In Mitochondrial DNA SE—11; Stuart, J., Ed.; Methods in Molecular Biology™, Humana Press: Clifton, NJ, USA, 2009; Volume 554, pp. 165–181.
124. Szczepanek, K.; Chen, Q.; Larner, A.C.; Lesnefsky, E.J. Cytoprotection by the modulation of mitochondrial electron transport chain: The emerging role of mitochondrial STAT3. Mitochondrion 2012, 12, 180–189.
125. Lieu, K.G.; Brice, A.; Wiltzer, L.; Hirst, B.; Jans, D.A.; Blondel, D.; Moseley, G.W. The rabies virus interferon antagonist P-protein interacts with activated STAT3 and inhibits Gp130 receptor signaling. J. Virol. 2013, 81, 8261–8265.
126. Mayer, M.P. Gymnastics of molecular chaperones. Mol. Cell 2010, 39, 321–331.
127. Mayer, M.P.; Bukau, B. Hsp70 chaperones: Cellular functions and molecular mechanism. Cell. Mol. Life Sci. 2005, 62, 670–684.
128. Lahaye, X.; Vidy, A.; Fouquet, B.; Blondel, D. Hsp70 protein positively regulates rabies virus infection. J. Virol. 2012,86, 4743–4751.
129. Silverman, M.N.; Sternberg, E.M. Glucocorticoid regulation of inflammation and its functional correlates: From HPA axis to glucocorticoid receptor dysfunction. Ann. N. Y. Acad. Sci. 2012, 1261, 55–63.
130. Schutsky, K.; Portocarrero, C.; Hooper, D.C.; Dietzschold, B.; Faber, M. Limited brain metabolism changes differentiate between the progression and clearance of rabies virus. PLoS ONE 2014, 9, e87180.
131. Burns, K.F.; Shelton, D.F.; Lukeman, J.M.; Grogan, E.W. Cortisone and ACTH impairment of response to rabies vaccine. Public Health Rep. 1960, 75, 441–445.
132. Enright, J.B.; Franti, C.E.; Frye, F.L.; Behymer, D.E. The effects of corticosteroids on rabies in mice. Can. J. Microbiol.1970, 16, 667–675.
133. Enright, J.B.; Goggin, J.E.; Frye, F.L.; Franti, C.E.; Behymer, D.E. Effects of corticosteroids on rabies virus infections in various animal species. J. Am. Vet. Med. Assoc. 1970, 156, 765–769.
134. Ciuchini, F.; Pestalozza, S.; Buonavoglia, C.; Di Trani, L.; Tollis, M.; Orfei, Z. Effects of corticosteroids mediated immunosuppression on the distribution of rabies vaccine virus in red foxes orally immunized against rabies.Zentralbl. Veterinarmed. B 1986, 33, 628–631.
135. Wiktor, T.J.; Doherty, P.C.; Koprowski, H. In vitro evidence of cell-mediated immunity after exposure of mice to both live and inactivated rabies virus. Proc. Natl. Acad. Sci. USA Immun. 1977, 74, 334–338.
136. Prabhakar, B.S.; Nathanson, N. Acute rabies death mediated by antibody. Nature 1981, 290, 590–591.
137. Andral, B.; Blancou, J. Study of the mechanisms of early death occurring after vaccination in mice inoculated with street rabies virus. Ann. L’inst. Pasteur Virol. 1981, 132, 503–517.
138. Sikes, R.K.; Cleary, W.F.; Koprowski, H.; Wiktor, T.J.; Kaplan, M.M. Effective protection of monkeys against death from street virus by post-exposure administration of tissue-culture rabies vaccine. Bull. World Health Organ. 1971, 45, 1–11.
139. Prabhakar, B.S.; Fischman, H.R.; Nathanson, N. Recovery from experimental rabies by adoptive transfer of immune cells. J. Gen. Virol. 1981, 56, 25–31.
140. Blancou, J.; Andral, B.; Andral, L. A model in mice for the study of the early death phenomenon after vaccination and challenge with rabies virus. J. Gen. Virol. 1980, 50, 433–435.
141. Vennema, H.; de Groot, R.J.; Harbour, D.A.; Dalderup, M.; Gruffydd-Jones, T.; Horzinek, M.C.; Spaan, W.J. Early death after feline infectious peritonitis virus challenge due to recombinant vaccinia virus immunization. J. Virol. 1990,64, 1407–1409.
142. Barrett, A.D.T.; Gould, E.A. Antibody-mediated early death in vivo after infection with yellow fever virus. J. Gen. Virol. 1986, 67, 2539–2542.
143. Shimizu, K.; Ito, N.; Sugiyama, M.; Minamoto, N. Sensitivity of rabies virus to type I interferon is determined by the phosphoprotein gene. Microbiol. Immunol. 2006, 50, 975–978.
144. Niu, X.; Tang, L.; Tseggai, T.; Guo, Y.; Fu, Z.F. Wild-type rabies virus phosphoprotein is associated with viral sensitivity to type I interferon treatment. Arch. Virol. 2013, 158, 2297–2305.
145. Chelbi-Alix, M.K.; Vidy, A.; El Bougrini, J.; Blondel, D. Rabies viral mechanisms to escape the IFN system: The viral protein P interferes with IRF-3, Stat1, and PML nuclear bodies. J. Interferon Cytokine Res. 2006, 26, 271–280.
146. Everett, R.D.; Chelbi-Alix, M.K. PML and PML nuclear bodies: Implications in antiviral defence. Biochimie 2007, 89, 819–830.
147. Regad, T.; Saib, A.; Lallemand-Breitenbach, V.; Pandolfi, P.P.; de Thé, H.; Chelbi-Alix, M.K. PML mediates the interferon-induced antiviral state against a complex retrovirus via its association with the viral transactivator. EMBO J. 2001, 20, 3495–3505.
148. Chenik, M.; Chebli, K.; Blondel, D. Translation initiation at alternate in-frame AUG codons in the rabies virus phosphoprotein mRNA is mediated by a ribosomal leaky scanning mechanism. J. Virol. 1995, 69, 707–712.
149. Blondel, D.; Regad, T.; Poisson, N.; Pavie, B.; Harper, F.; Pandolfi, P.P.; De Thé, H.; Chelbi-Alix, M.K. Rabies virus P and small P products interact directly with PML and reorganize PML nuclear bodies. Oncogene 2002, 21, 7957–7970.
150. Blondel, D.; Kheddache, S.; Lahaye, X.; Dianoux, L.; Chelbi-Alix, M.K. Resistance to rabies virus infection conferred by the PMLIV isoform. J. Virol. 2010, 84, 10719–10726.
151. Goodbourn, S.; Didcock, L.; Randall, R.E. Interferons: Cell signalling, immune modulation, antiviral responses and virus countermeasures. J. Gen. Virol. 2000, 81, 2341–2364.
152. Pasdeloup, D.; Poisson, N.; Raux, H.; Gaudin, Y.; Ruigrok, R.W.H.; Blondel, D. Nucleocytoplasmic shuttling of the rabies virus P protein requires a nuclear localization signal and a CRM1-dependent nuclear export signal. Virology 2005, 334, 284–293.
153. Wiltzer, L.; Larrous, F.; Oksayan, S.; Ito, N.; Marsh, G.A.; Wang, L.F.; Blondel, D.; Bourhy, H.; Jans, D.A.; Moseley, G.W. Conservation of a unique mechanism of immune evasion across the Lyssavirus genus. J. Virol. 2012, 86, 10194–10199.
154. Brzózka, K.; Finke, S.; Conzelmann, K.K. Inhibition of interferon signaling by rabies virus phosphoprotein P: Activation-dependent binding of STAT1 and STAT2. J. Virol. 2006, 80, 2675–2683.
155. Vidy, A.; Chelbi-alix, M.; Blondel, D. Rabies virus P protein interacts with STAT1 and inhibits interferon signal transduction pathways. J. Virol. 2005, 79, 14411–14420.
156. Wiltzer, L.; Okada, K.; Yamaoka, S.; Larrous, F.; Kuusisto, H.V.; Sugiyama, M.; Blondel, D.; Bourhy, H.; Jans, D.A.; Ito, N.; et al. Interaction of rabies virus P-protein with STAT proteins is critical to lethal rabies disease. J. Infect. Dis. 2014,209, 1744–1753.
157. Ito, N.; Moseley, G.W.; Blondel, D.; Shimizu, K.; Rowe, C.L.; Ito, Y.; Masatani, T.; Nakagawa, K.; Jans, D.A.; Sugiyama, M. Role of interferon antagonist activity of rabies virus phosphoprotein in viral pathogenicity. J. Virol. 2010, 84, 6699–6710.
158. Heinrich, P.C.; Behrmann, I.; Müller-Newen, G.; Schaper, F.; Graeve, L. Interleukin-6-type cytokine signalling through the gp130/Jak/STAT pathway. Biochem. J. 1998, 334(Pt 2), 297–314.
159. Marschalek, A.; Drechsel, L.; Conzelmann, K.K. The importance of being short: The role of rabies virus phosphoprotein isoforms assessed by differential IRES translation initiation. Eur. J. Cell Biol. 2011, 20, 3–9.
160. Vidy, A.; El Bougrini, J.; Chelbi-alix, M.K.; Blondel, D. The Nucleocytoplasmic rabies virus P protein counteracts interferon signaling by inhibiting both nuclear accumulation and DNA binding of STAT1. J. Virol. 2007, 81, 4255–4263.
161. Mori, M.; Yoneyama, M.; Ito, T.; Takahashi, K.; Inagaki, F.; Fujita, T. Identification of Ser-386 of interferon regulatory factor 3 as critical target for inducible phosphorylation that determines activation. J. Biol. Chem. Mol. Biol. 2004, 279, 9698–9702.
162. Brzozka, K.; Finke, S.; Conzelmann, K.K. Identification of the rabies virus alpha/beta interferon antagonist: Phosphoprotein P interferes with phosphorylation of interferon regulatory factor 3. J. Virol. 2005, 79, 7673–7681.
163. Rieder, M.; Brzózka, K.; Pfaller, C.K.; Cox, J.H.; Stitz, L.; Conzelmann, K.K. Genetic dissection of interferon-antagonistic functions of rabies virus phosphoprotein: Inhibition of interferon regulatory factor 3 activation is important for pathogenicity. J. Virol. 2011, 85, 842–852.
164. Faul, E.J.; Wanjalla, C.N.; Suthar, M.S.; Gale, M.; Wirblich, C.; Schnell, M.J. Rabies virus infection induces type I interferon production in an IPS-1 dependent manner while dendritic cell activation relies on IFNAR signaling. PLoS Pathog. 2010, 6, e1001016.
165. Li, J.; McGettigan, J.P.; Faber, M.; Schnell, M.J.; Dietzschold, B. Infection of monocytes or immature dendritic cells (DCs) with an attenuated rabies virus results in DC maturation and a strong activation of the NFkappaB signaling pathway. Vaccine 2008, 26, 419–426.
166. Albertini, A.A.V.; Wernimont, A.K.; Muziol, T.; Ravelli, R.B.G.; Clapier, C.R.; Schoehn, G.; Weissenhorn, W.; Ruigrok, R.W.H. Crystal structure of the rabies virus nucleoprotein-RNA complex. Science 2006, 313, 360–363.
167. Masatani, T.; Ito, N.; Shimizu, K.; Ito, Y.; Nakagawa, K.; Abe, M.; Yamaoka, S.; Sugiyama, M. Amino acids at positions 273 and 394 in rabies virus nucleoprotein are important for both evasion of host RIG-I-mediated antiviral response and pathogenicity. Virus Res. 2011, 155, 168–174.
168. Masatani, T.; Ito, N.; Shimizu, K.; Ito, Y.; Nakagawa, K.; Sawaki, Y.; Koyama, H.; Sugiyama, M. Rabies virus nucleoprotein functions to evade activation of the RIG-I-mediated antiviral response. J. Virol. 2010, 84, 4002–4012.
169. Masatani, T.; Ito, N.; Ito, Y.; Nakagawa, K.; Abe, M.; Yamaoka, S.; Okadera, K.; Sugiyama, M. Importance of rabies virus nucleoprotein in viral evasion of interferon response in the brain. Microbiol. Immunol. 2013, 57, 511–517.
170. Mebatsion, T.; Weiland, F.; Conzelmann, K.K. Matrix protein of rabies virus is responsible for the assembly and budding of bullet-shaped particles and interacts with the transmembrane spike glycoprotein G. J. Virol. 1999, 73, 242–250.
171. Komarova, A.V.; Real, E.; Borman, A.M.; Brocard, M.; England, P.; Tordo, N.; Hershey, J.W.B.; Kean, K.M.; Jacob, Y. Rabies virus matrix protein interplay with eIF3, new insights into rabies virus pathogenesis. Nucleic Acids Res. 2007,35, 1522–1532.
172. Wirblich, C.; Tan, G.S.; Papaneri, A.; Godlewski, P.J.; Orenstein, J.M.; Harty, R.N.; Schnell, M.J. PPEY motif within the rabies virus (RV) matrix protein is essential for efficient virion release and RV pathogenicity. J. Virol. 2008, 82, 9730–9738.
173. Liu, Y.-C. Ubiquitin Ligases and the Immune Response. Annu. Rev. Immunol. 2004, 22, 81–127.
174. Sonwane, A.A.; Dahiya, S.S.; Saini, M.; Chaturvedi, V.K.; Singh, R.P.; Gupta, P.K. Inhibition of rabies virus multiplication by siRNA delivered through adenoviral vector in vitro in BHK-21 cells and in vivo in mice. Res. Vet. Sci. 2012, 93, 498–503.
175. Meshram, C.D.; Singh, N.K.; Sonwane, A.A.; Pawar, S.S.; Mishra, B.P.; Chaturvedi, V.K.; Saini, M.; Singh, R.P.; Gupta, P.K. Evaluation of single and dual siRNAs targeting rabies virus glycoprotein and nucleoprotein genes for inhibition of virus multiplication in vitro. Arch. Virol. 2013, 158, 2323–2332.
176. Singh, N.K.; Meshram, C.D.; Sonwane, A.A.; Dahiya, S.S.; Pawar, S.S.; Chaurvedi, V.K.; Saini, M.; Singh, R.P.; Gupta, P.K. Protection of mice against lethal rabies virus challenge using ihort interfering RNAs (siRNAs) delivered through lentiviral vector. Mol. Biotechnol. 2013, 56, 91–101.
177. Israsena, N.; Mahavihakanont, A.; Hemachudha, T. Rabies virus infection and microRNAs. Adv. Virus Res. 2011, 79, 329–344.
178. Gupta, P.K.; Sonwane, A.A.; Singh, N.K.; Meshram, C.D.; Dahiya, S.S.; Pawar, S.S.; Gupta, S.P.; Chaturvedi, V.K.; Saini, M. Intracerebral delivery of small interfering RNAs (siRNAs) using adenoviral vector protects mice against lethal peripheral rabies challenge. Virus Res. 2012, 163, 11–18.
179. Brandão, P.E.; Castilho, J.G.; Fahl, W.; Carnieli, P., Jr.; Oliveira, R.D.N. Short-interfering RNAs as antivirals Against Rabies. Braz. J. Infect. Dis. 2007, 11, 224–225.
180. Wu, H.X.; Wang, H.L.; Guo, X.F.; Yang, Y.J.; Ma, J.Z.; Wang, T.C.; Gao, Y.W.; Zhao, Y.K.; Yang, S.T.; Xia, X.Z. Adeno-associated viruses serotype 2-mediated RNA interference efficiently inhibits rabies virus Replication In Vitro and In Vivo. J. Vet. Med. Sci. 2013, 75, 1355–1361.
181. Kim, D.H.; Rossi, J.J. Strategies for silencing human disease using RNA interference. Nat. Rev. Genet. 2007, 8, 173–184.
182. Liang, H.; Hu, G.; Zhang, T.; Yang, Y.; Zhao, L.; Qi, Y.; Wang, H.; Goa, Y.; Yang, S.; Xia, X. Isolation of ssDNA aptamers that inhibit rabies virus. Int. Immunopharmacol. 2012, 14, 341–347.
183. Israsena, N.; Supavonwong, P.; Ratanasetyuth, N.; Khawplod, P.; Hemachudha, T. Inhibition of rabies virus replication by multiple artificial microRNAs. Antivir. Res. 2009, 84, 76–83.
184. Zhao, P.; Zhao, L.; Zhang, T.; Wang, H.; Qin, C.; Yang, S.; Xia, X. Changes in microRNA expression induced by rabies virus infection in mouse brains. Microb. Pathog. 2011, 52, 47–54.
185. Taylor, L.H.; Nel, L.H. Global epidemiology of canine rabies: Past, present, and future prospects. Vet. Med. Res. Rep.2015, 6, 361–371.
186. McFadden, G. Killing a killer: What next for smallpox? PLoS Pathog. 2010, 6, e1000727.
187. Guerra, M.A.; Curns, A.T.; Rupprecht, C.E.; Hanlon, C.A.; Krebs, J.W.; Childs, J.E. Skunk and raccoon rabies in the eastern United States: Temporal and spatial analysis. Emerg. Infect. Dis. 2003, 9, 1143–1150.
188. Hass, C.C.; Dragoo, J.W. Rabies in hooded and striped skunks in Arizona. J. Wildl. Dis. 2006, 42, 825–829.
189. Scott, T.P.; Fischer, M.; Khaiseb, S.; Freuling, C.M.; Hoper, D.; Hoffmann, B.; Markotter, W.; Muller, T.; Nel, L.H. Complete genome and molecular epidemiological data infer the maintenance of rabies among kudu (Tragelaphus strepsiceros) in Namibia. PLoS ONE 2013, 8, e58739.
190. Baby, J.; Mani, R.S.; Abraham, S.S.; Thankappan, A.T.; Pillai, P.M.; Anand, A.M.; Madhusudana, S.N.; Ramachandran, J.; Sreekumar, S. Natural rabies infection in a domestic fowl (Gallus domesticus): A Report from India. PLoS Negl. Trop. Dis. 2015, 9, e0003942.
191. Banyard, A.C.; Evans, J.S.; Luo, T.R.; Fooks, A.R. Lyssaviruses and bats: Emergence and zoonotic threat. Viruses 2014,6, 2974–2990.
192. Wickersham, I.R.; Finke, S.; Conzelmann, K.K.; Callaway, E.M. Retrograde neuronal tracing with a deletion-mutant rabies virus. Nat. Meth. 2007, 4, 47–49.
193. Osakada, F.; Mori, T.; Cetin, A.H.; Marshel, J.H.; Virgen, B.; Callaway, E.M. New Rabies virus variants for monitoring and manipulating activity and gene expression in defined neural circuits. Neuron 2011, 71, 617–631.